Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Cau MC"'
3
Akademický článek
First-line cetuximab + platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE.
Autor: Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; INSERM U900 Research Unit, Saint-Cloud, France.; Faculty of Medicine, Paris-Saclay University, Paris, France., Ghiani M; Department of Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy., Cau MC; Department of Oncology, Azienda Ospedaliera Brotzu, Cagliari, Italy., Depenni R; Department of Oncology and Hematology, Università degli Studi di Modena e Reggio Emilia, Modena, Italy., Ronzino G; Oncology Unit, Ospedale, Vito Fazzi, Lecce, Italy., Bonomo P; Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Montesarchio V; AORN dei Colli, Monaldi Hospital, Naples, Italy., Leo L; AORN dei Colli, Monaldi Hospital, Naples, Italy., Schulten J; Global Medical Unit Oncology, Merck Healthcare KGaA, Darmstadt, Germany., Salmio S; Global Medical Unit Oncology, Merck Healthcare KGaA, Darmstadt, Germany., Messinger D; Statistics, Prometris GmbH, Mannheim, Germany., Sbrana A; Service of Pneumo-Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Ghi MG; Oncology Unit 2, Istituto Oncologico Veneto-IRCCS, Padova, Italy.
Publikováno v: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2023 May; Vol. 6 (5), pp. e1804. Date of Electronic Publication: 2023 Apr 17.
Zobrazit plný text záznamu
4
Akademický článek
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands.
Autor: Cavalieri S; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy. Electronic address: stefano.cavalieri@istitutotumori.mi.it., Mariani L; Clinical Epidemiology and Trial Organization Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Vander Poorten V; Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven and Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium., Van Breda L; Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven and Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium., Cau MC; Medical Oncology Unit, Azienda Ospedaliera Brotzu, Cagliari, Italy., Lo Vullo S; Clinical Epidemiology and Trial Organization Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Alfieri S; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Resteghini C; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Bergamini C; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Orlandi E; Radiotherapy 1-2 Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Calareso G; Radiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Clement P; Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Hauben E; Department of Pathology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium., Platini F; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Bossi P; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Licitra L; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Italy., Locati LD; Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Sep; Vol. 136, pp. 35-42. Date of Electronic Publication: 2020 Jul 03.
Zobrazit plný text záznamu
5
Akademický článek
Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy.
Autor: Siano M; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy; Cantonal Hospital St. Gallen, Dept. of Med. Oncology and Hematology, Rorschacherstrasse 95, CH-9007 St. Gallen, Switzerland. Electronic address: marco.siano@kssg.ch., Infante G; Fondazione IRCCS I.N.T., Clin. Epidemiology and Trials Org. Unit, I-20133 Milan, Italy; Politecnic University Milan, Piazza Leonardo da Vinci, 32, I-20133 Milano, Italy., Resteghini C; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Cau MC; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Alfieri S; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Bergamini C; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Granata R; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Miceli R; Fondazione IRCCS I.N.T., Clin. Epidemiology and Trials Org. Unit, I-20133 Milan, Italy., Locati L; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy., Licitra L; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy; State University of Milan, Via Festa del Perdono, 7, I-20122 Milano, Italy., Bossi P; Fondazione IRCCS Istituto Nazionale dei Tumori, Head and Neck Medical Oncology Dept., Via Venezian 1, I-20133 Milan, Italy.
Publikováno v: Oral oncology [Oral Oncol] 2017 Jun; Vol. 69, pp. 33-37. Date of Electronic Publication: 2017 Apr 09.
Zobrazit plný text záznamu
6
Akademický článek
Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome.
Autor: Madeddu C; Department of Medical Oncology, University of Cagliari, Cagliari, Italy., Dessì M, Panzone F, Serpe R, Antoni G, Cau MC, Montaldo L, Mela Q, Mura M, Astara G, Tanca FM, Macciò A, Mantovani G
Publikováno v: Clinical nutrition (Edinburgh, Scotland) [Clin Nutr] 2012 Apr; Vol. 31 (2), pp. 176-82. Date of Electronic Publication: 2011 Nov 01.
Zobrazit plný text záznamu
7
Akademický článek
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.
Autor: Macciò A; Department of Obstetrics and Gynecology, Sirai Hospital, Carbonia, Italy. a.maccio@tin.it, Madeddu C, Gramignano G, Mulas C, Floris C, Sanna E, Cau MC, Panzone F, Mantovani G
Publikováno v: Gynecologic oncology [Gynecol Oncol] 2012 Mar; Vol. 124 (3), pp. 417-25. Date of Electronic Publication: 2011 Dec 20.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje